GO
Loading...
 

Biogen IDEC CEO on Multiple Sclerosis Pill

Thu 28 Mar 13 | 04:35 PM ET
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

Biogen IDEC CEO on Multiple Sclerosis Pill

Thu 28 Mar 13 | 04:35 PM ET
Biotech has returned 20 percent for investors this year. Biogen IDEC CEO George Scangos, discusses the recent FDA approval of his company's drug, which is its first pill for multiple sclerosis.
 
RELATED ARTICLES AND CONTENT
More Videos
Latest Videos
Visa reports beat on earnings
Thu 24 Apr 14 | 04:15 PM ET
Latest Videos
Starbucks Q2 earnings in line
Thu 24 Apr 14 | 04:14 PM ET
Latest Videos
Buying opportunity at Amazon: Pro
Thu 24 Apr 14 | 04:06 PM ET
Latest Videos
Pandora reports Q1 loss
Thu 24 Apr 14 | 04:06 PM ET
Go
Displaying results for: Latest Video | US